07:32 EDT MannKind (MNKD) to acquire scPharmaceuticals (SCPH) for up to $6.35 per share in cash
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MNKD:
- MannKind’s Growth Potential and Stability: Buy Rating Reinforced by Pipeline Progress and Strategic Catalysts
- MannKind Corporation’s Earnings Call Highlights Growth and Challenges
- MannKind Corporation Reports Q2 2025 Financial Growth
- Promising Outlook for MannKind: Buy Rating Justified by Clinical Progress and Financial Strength
- MannKind’s Strategic Growth Potential and Undervalued Stock: A Buy Rating Amid Market Overreactions